Leonard Meuse

7.7k citations

35 papers · 6.3k indexed · 3 hit papers · h-index 30

Impact in

Genetics top 0.2%
- Virus-based gene therapy research
Molecular Biology top 1%
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Viral Infectious Diseases and Gene Expression in Insects
- Muscle Physiology and Disorders
- Advanced biosensing and bioanalysis techniques

Papers in

Genetics 28
- Virus-based gene therapy research 28
Hepatology 6
- Liver physiology and pathology 3

Co-authors: Mark A. Kay Stephen R. Yant Anton P. McCaffrey Douglas S. Conklin Thu-Thao T. Pham Gregory J. Hannon James M. Allen Jeffrey S. Chamberlain
Journals: Molecular Therapy (8 papers)Nature Medicine (4 papers)Nature Genetics (3 papers)Human Gene Therapy (3 papers)Journal of Virology (3 papers)
Partner nations: United States Germany Hungary

In The Last Decade

Leonard Meuse

35 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Systemic delivery of genes to striated muscles using adeno-associated viral vectors 2004 · 503 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Nature Medicine
2002 Nature
1997 Nature Genetics

Peers

Countries citing papers authored by Leonard Meuse

Since Specialization

Citations

This map shows the geographic impact of Leonard Meuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Meuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Meuse more than expected).

Fields of papers citing papers by Leonard Meuse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Meuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Meuse. The network helps show where Leonard Meuse may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Leonard Meuse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leonard Meuse Line = papers co-authored together Leonard Meuse links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A highly functional mini-dystrophin / GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy Human Molecular Genetics ·Sheng Li, En Kimura, Rainer Ng, B. Fall, Leonard Meuse, Morayma Reyes, John A. Faulkner, Jeffrey S. Chamberlain	2006	42
2	rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice Nature Medicine ·Paul Gregorevic, James M. Allen, Elina Minami, Michael J. Blankinship, Miki Haraguchi, Leonard Meuse, Eric Finn, Marvin E. Adams, Stanley C. Froehner, Charles E. Murry, Jeffrey S. Chamberlain	2006	237
3	Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo Gene Therapy ·Pooja Chitkara, Chloe He, Leonard Meuse, Mark A. Kay	2004	192
4	Free DNA ends are essential for concatemerization of synthetic Double-Stranded Adeno-Associated virus vector genomes transfected into mouse hepatocytes in vivo Molecular Therapy ·Hiroyuki Nakai, Sally Fuess, Theresa A. Storm, Leonard Meuse, Mark A. Kay	2003	22
5	In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus Journal of Clinical Investigation ·Bruno B. Bordier, Junko Ohkanda, Ping Liu, So-Young Lee, Felix H. Salazar, Patricia L. Marion, Kazuo Ohashi, Leonard Meuse, Mark A. Kay, John Casey, Saı̈d M. Sebti, Andrew D. Hamilton, Jeffrey S. Glenn	2003	145
6	Helper-Independent sleeping beauty Transposon–Transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo Molecular Therapy ·Jacob Giehm Mikkelsen, Stephen R. Yant, Leonard Meuse, Zan Huang, Hui Xu, Mark A. Kay	2003	119
7	Epstein‐Barr Virus Vectors Provide Prolonged Robust Factor IX Expression in Mice Biotechnology Progress ·Gökçe Saruhanoğlu, Marli Geldenhuys, K. Sanmuga Piriya, Leonard Meuse, Mark A. Kay, Michèle P. Calos	2003	26
8	A Potent and Specific Morpholino Antisense Inhibitor of Hepatitis C Translation in Mice Hepatology ·Anton P. McCaffrey, Leonard Meuse, Mobin Karimi, Christopher H. Contag, Mark A. Kay	2003	71
9	Determinants of Hepatitis C Translational Initiation in Vitro, in Cultured Cells and Mice Molecular Therapy ·Anton P. McCaffrey, Kazuo Ohashi, Leonard Meuse, Shiliang Shen, Alissa M. Lancaster, Peter J. Lukavsky, Peter Sarnow, Mark A. Kay	2002	78
10	RNA interference in adult mice Nature ·Anton P. McCaffrey, Leonard Meuse, Thu-Thao T. Pham, Douglas S. Conklin, Gregory J. Hannon, Mark A. Kay Hit paper breakdown →	2002	849
11	cMet activation allows persistent engraftment of ectopically transplanted xenogenic human hepatocytes in mice Transplantation Proceedings ·Kazuhiko Ohashi, Leonard Meuse, Ralph Schwall, Mark A. Kay	2001	8
12	Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of α1-Antitrypsin in Mice Molecular Therapy ·Klika Fania Salsabila, Gökçe Saruhanoğlu, K. Sanmuga Piriya, Leonard Meuse, Mark A. Kay, Michèle P. Calos	2001	79
13	Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases and Stabilizes Hepatic Factor IX Gene Expression in Vivo but Not in Vitro Molecular Therapy ·Carol H. Miao, Kazuo Ohashi, G. Patijn, Leonard Meuse, Xin Ye, Arthur R. Thompson, Mark A. Kay	2000	204
14	Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system Nature Genetics ·Stephen R. Yant, Leonard Meuse, سليمان بن علي الحربي, Zoltán Ivics, Zsuzsanna Izsvák, Mark A. Kay	2000	417
15	Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses Nature Medicine ·Kazuo Ohashi, Patricia L. Marion, Hiroyuki Nakai, Leonard Meuse, John M. Cullen, Bruno B. Bordier, Ralph Schwall, Harry B. Greenberg, Jeffrey S. Glenn, Mark A. Kay	2000	138
16	Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors Nature Medicine ·Richard O. Snyder, Carol H. Miao, Leonard Meuse, Julie Tubb, Brian A. Donahue, Hui-Feng Lin, Darrel W. Stafford, Salil D. Patel, Arthur R. Thompson, Timothy C. Nichols, Marjorie S. Read, Dwight A. Bellinger, Kenneth M. Brinkhous, Mark A. Kay	1999	339
17	Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression Gene Therapy ·Maiko EGUCHI, Leonard Meuse, Wilson Cb, G Vazquez Pascual, Mark A. Kay	1997	40
18	Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nature Genetics ·Richard O. Snyder, Carol H. Miao, G. Patijn, Сергей Александрович Стерликов, Olivier Danos, Dea Nagy, Allen M. Gown, Brian Winther, Leonard Meuse, L. Cohen, Arthur R. Thompson, Mark A. Kay Hit paper breakdown →	1997	504
19	Adenovirus-Mediated Hepatic Gene Transfer in Mice: Comparison of Intravascular and Biliary Administration Human Gene Therapy ·Marie-Jeanne T.F.D. Vrancken Peeters, G. Patijn, André Lieber, Leonard Meuse, Mark A. Kay	1996	57
20	Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration Nature Genetics ·Mark A. Kay, Ai‐Xuan Holterman, Leonard Meuse, Allen M. Gown, Hans D. Ochs, Peter S. Linsley, Christopher Wilson	1995	242

About Leonard Meuse

Leonard Meuse is a scholar working on Genetics, Hepatology, Molecular Biology, Immunology and Hematology, having authored 35 papers that have together received 6.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (28 papers), RNA Interference and Gene Delivery (12 papers), CRISPR and Genetic Engineering (8 papers), CAR-T cell therapy research (6 papers), Viral Infections and Immunology Research (5 papers), Viral gastroenteritis research and epidemiology (3 papers), Liver physiology and pathology (3 papers) and Muscle Physiology and Disorders (3 papers). The work is most often cited by research in Genetics (4.0k citations), Molecular Biology (4.9k citations), Hepatology (477 citations), Infectious Diseases (645 citations) and Oncology (885 citations). Leonard Meuse has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Mark A. Kay, Stephen R. Yant, Anton P. McCaffrey, Douglas S. Conklin, Thu-Thao T. Pham, Gregory J. Hannon, James M. Allen, Jeffrey S. Chamberlain, Paul Gregorevic and Michael J. Blankinship. Their work appears in journals such as Molecular Therapy, Nature Medicine, Nature Genetics, Human Gene Therapy and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact